MEX3A promotes proliferation and migration of colorectal cancer cells via PI3K/Akt signaling pathway

YAN Ting

doi:10.16098/j.issn.0529-1356.2022.02.009

PDF(9563 KB)

Acta Anatomica Sinica ›› 2022, Vol. 53 ›› Issue (2) : 196-202. DOI: 10.16098/j.issn.0529-1356.2022.02.009

Cancer Biology

MEX3A promotes proliferation and migration of colorectal cancer cells via PI3K/Akt signaling pathway

YAN Ting^1,2 ZHAO Ji-kai³ WANG En-hua^1*

Author information +

History +

Abstract

Objective To investigate the expression of MEX3A in colorectal cancer (CRC), and to explore the effect and mechanism of MEX3A on the proliferation and migration of colorectal cancer cells. Methods Totally 327 cases of data(41 normal tissues and 286 tumor tissues) were obtained from TCGA database, and 104 cases of clinical samples(77 cases tissues and 27 paracancerous tissues) were collected for immunohistochemistry, then analysed the differences in MEX3A expression between CRC tissues and normal tissues. Western blotting and immunofluorescence staining were used to evaluate the differential expression of MEX3A in CRC cell lines. CL187 cells were selected as the follow-up research vector. Small interfering RNA of MEX3A(siMEX3A) was transfected into CL187 cells to inhibit the expression of MEX3A. The proliferation and migration of CL187 cells were measured by MTT, colony formation assay and Transwell assay. The expression of PI3K, p-PI3K, Akt and p-Akt were detected by Western blotting. Results TCGA database, immunohistochemistry and Western blotting analysis showed that MEX3A was highly expressed in colorectal cancer. The result of immunofluorescence staining showed that MEX3A was concentrated in the cytoplasm and the nucleus. In MTT, colony formation assay and Transwell assay, the proliferation and migration ability of CL187 cells in siMEX3A group decreased significantly than those in control group (P<0.05). Western blotting result showed that the expression of p-PI3K and p-Akt in siMEX3A group down-regulated significantly (P<0.05), and the inhibition of proliferation and migration ability of CL187 cells induced by siMEX3A group could be reversed by 740 Y-P via activating the PI3K/Akt signaling pathway. Conclusion MEX3A is highly expressed in colorectal cancer and promotes the proliferation and migration of CRC cells via PI3K/Akt signaling pathway.

Key words

MEX3A / Gene sliencing / Colorectal cancer / Cell proliferation / Cell migration / Phosphatidylinositol 3-kinase/protein kinase B signaling pathway / Immunohistochemistry / Human

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

YAN Ting ZHAO Ji-kai WANG En-hua. MEX3A promotes proliferation and migration of colorectal cancer cells via PI3K/Akt signaling pathway[J]. Acta Anatomica Sinica. 2022, 53(2): 196-202 https://doi.org/10.16098/j.issn.0529-1356.2022.02.009

References

［1］ Wu ChX, Gu Kai, Gong YM,et al. Analysis of incidence and mortality of colorectal cancer in China, 2015［J］. China Oncology, 2020,30(4):241-245. (in Chinese)

吴春晓,顾凯,龚杨明,等.2015年中国结直肠癌发病和死亡情况分析［J］.中国癌症杂志,2020,30(4):241-245.

［2］ Zheng Sh, Zhang SZh, Huang YQ. Review and present situation of colorectal cancer research in 30 years［J］. Journal of Practical Oncology, 2016,31(1):2-5. (in Chinese)

郑树,张苏展,黄彦钦.结直肠癌研究30年回顾和现状［J］.实用肿瘤杂志,2016,31(1):2-5.

［3］ Brenner H, Kloor M, Pox CP. Colorectal cancer［J］. Lancet,2014,383(9927):1490-1502.

［4］ Buchet-Poyau K, Courchet J, Le Hir H, et al. Identification and characterization of human Mex-3 proteins, a novel family of evolutionarily conserved RNA-binding proteins differentially localized to processing bodies［J］. Nucleic Acids Res,2007,35(4):1289-1300.

［5］ Zhu YB, Wang YY, Xing ShG, et al. Molecular mechanism of miR-520c-3p targeting MEX3A in regulating proliferation and apoptosis of lung cancer cells［J］. Current Immunology,2020,40,(4):281-288.(in Chinese)

祝远彬,王营营,邢士刚,等.miR-520c-3p靶向MEX3A调控肺癌细胞增殖、凋亡的分子机制［J］.现代免疫学,2020,40(4):281-288.

［6］ Yang D, Jiao Y, Li Y, et al. Clinical characteristics and prognostic value of MEX3A mRNA in liver cancer［J］. PeerJ,2020,8:e8252.

［7］ Fang Ch, Yin J, Yu QSh, et al. Effects of RNA interference targeting MEX3A gene on proliferation and apoptosis of human bladder cancer cell［J］. Acta Anatomica Sinica, 2017,48(6):688-692. (in Chinese)

房超,尹晶,于秋爽, 等.RNA干扰MEX3A基因对膀胱癌细胞增殖和凋亡的影响［J］.解剖学报,2017,48(6):688-692.

［8］ Jemal A, Bray F, Center MM, et al. Global cancer statistics［J］. CA Cancer J Clin,2011,61(2):69-90.

［9］ Connell LC, Mota JM, Braghiroli MI, et al. The rising incidence of younger patients with colorectal cancer: questions about screening, biology, and treatment［J］. Curr Treat Options Oncol, 2017,18(4):23.

［10］ Pereira B, Le Borgne M, Chartier NT, et al. MEX-3 proteins: recent insights on novel post-transcriptional regulators［J］.Trends Biochem Sci, 2013,38(10):477-479.

［11］ Barriga FM, Montagni E, Mana M, et al. Mex3a marks a slowly dividing subpopulation of Lgr5+ intestinal stem cells［J］. Cell Stem Cell,2017,20(6):801-816.

［12］ Pereira B, Sousa S, Barros R, et al. CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness［J］. Nucleic Acids Res,2013,41(7):3986-3999.

［13］ Pereira B, Amaral AL, Dias A, et al. MEX3A regulates Lgr5+ stem cell maintenance in the developing intestinal epithelium［J］. EMBO Rep,2020,21(4):e48938.

［14］ Chatterji P, Rustgi AK. RNA Binding proteins in intestinal epithelial biology and colorectal cancer［J］. Trends Mol Med,2018,24(5):490-506.

［15］ Zhu B, Guo XP, Dong TQ, et al. Expression level and function of MEX3A in non-small cell lung cancer［J］. Chinese Journal of Clinical Oncology,202047(15):763-768.(in Chinese)

朱贝,郭小朋,董天祺,等.MEX3A在非小细胞肺癌中的表达与功能研究［J］.中国肿瘤临床,2020,47(15):763-768.

［16］ Jiang H, Zhang X, Luo J, et al. Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells［J］. Mol Med Rep,2012,6(3):575-580.

［17］ Koveitypour Z, Panahi F, Vakilian M, et al. Signaling pathways involved in colorectal cancer progression［J］. Cell Biosci,2019,2(9):97.

［18］ Bahrami A, Khazaei M, Hasanzadeh M,et al. Therapeutic potential of targeting PI3K/AKT pathway in treatment of colorectal cancer: rational and progress［J］. J Cell Biochem,2018,119(3):2460-2469.

［19］ Yue FR, Peng KY, Zhang L. The expression of PI3K/AKT/mTOR pathway in colorectal cancer and its targeted therapy［J］: Modern Digestion & Intervention, 2020,25(2):178-182. (in Chinese)

岳芙蓉,彭科瑜,张力.PI3K/AKT/mTOR通路在结直肠癌中的表达及靶向治疗研究［J］.现代消化及介入诊疗,2020,25(2):178-182.

［20］ Pandurangan AK. Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways［J］. Asian Pac J Cancer Prev,2013,14(4):2201-2205.

［21］ Zhang JJ, Xu WR, Chen B, et al. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway［J］. Eur Rev Med Pharmacol Sci,2019,23(19):8321-8331.

［22］ Gong Q, Chen J. The research status about the relationship between PTEN/PI3K/Akt signal transduction pathway and colorectal cancer［J］. Chinese Journal of Gastroenterology and Hepatology, 2016,25(6):706-710. (in Chinese)

龚青,陈洁.PTEN/PI3K/Akt信号转导通路与结直肠癌关系的研究现状［J］.胃肠病学和肝病学杂志,2016,25(6):706-710.

［23］ Tang Y, Liu P, Tian Y, et al. Overexpression of ribonuclease inhibitor defines good prognosis and suppresses proliferation and metastasis in human colorectal cancer cells via PI3K/AKT pathway［J］. Clin Transl Oncol,2015,17(4):306-313.

［24］ Liang J, Li H, Han J, et al. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway［J］. Cell Death Dis,2020,11(8):614.

［25］ Jiang S, Meng L, Chen X, et al. MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway［J］. Exp Cell Res,2020,395(2):112191.